Related Experiment Videos
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
S Jackson1, K Bartlett, J Land
1Department of Clinical Neuroscience, University of Newcastle upon Tyne, United Kingdom.
Pediatric Research
|April 1, 1991
Summary
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, a metabolic disorder, causes acute crises in children. Diagnosis involves identifying specific urinary acids and low enzyme activity in skin cells.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is an inherited metabolic disorder affecting fatty acid oxidation.
- Early diagnosis and understanding of LCHAD deficiency are crucial for patient management.
Observation:
- Two pediatric patients presented with acute metabolic crises, characterized by hypoglycemia.
- Urinary analysis revealed the excretion of even-chain unsubstituted dicarboxylic and 3-hydroxy-dicarboxylic acids.
Findings:
- Enzyme assays in cultured skin fibroblasts demonstrated deficient long-chain 3-hydroxyacyl-CoA dehydrogenase activity.
- Normal short-chain 3-hydroxyacyl-CoA dehydrogenase activity was confirmed using monospecific antibodies.
- Evidence suggests an autosomal recessive inheritance pattern, with intermediate enzyme activity in parental fibroblasts.
Implications:
- This study highlights key clinical and biochemical markers for diagnosing LCHAD deficiency.
- Understanding the enzymatic defect aids in genetic counseling and potential therapeutic strategies.
- Further research into fatty acid oxidation disorders can improve patient outcomes.